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S36 IgA Nephropathyhours, daytime and nighttime systolic and diastolic BP variations were calcu-
lated. The patients were divided into four groups based on different circa-
dian BP rhythm: dippers, non-dippers, reversed dippers, and extreme
dippers. Demographic and clinicopathologic data were collected and
analyzed. Logistic regression models were used to analyze the associated fac-
tors for abnormal BP rhythms among the patients with IgAN.
Results: A total of 375 IgAN patients were recruited and the mean age was
(36.5 11.7) years with 51.7% (194/375) men. The prevalence of abnormal
circadian BP was high to 84% (315/375), with 82.4% in normotensive and
86.1% in hypertensive patients (P > 0.05). The non-dipper rhythm was the
most common abnormal pattern (63.8%, 239/375), and then was reversed
dipper (27.3%, 86/315), extreme dipper (8.9%, 28/315). Compared to the pa-
tients with normal BP rhythm, the patients with abnormal BP rhythms had
higher left ventricular mass index, higher serum creatinine and uric acid but
lower eGFR, higher proportion of arteriole wall thickening and small vascular
hyalinosis, which was the most distinguishing in those with reversed dipper
BP. Multivariate logistic regression analysis revealed that the eGFR (OR: 0.64,
95% CI: 0.45e0.93, PZ 0.037), serum uric acid (OR: 1.60, 95% CI: 1.01e2.54,
P Z 0.014) and small vascular hyalinosis (OR: 2.17, 95% CI: 1.14e4.11,
PZ 0.044)were independently associatedwith abnormal BP circadian rhythm.
Conclusion: Abnormal circadian BP rhythm was common in IgAN patients inde-
pendent of hypertension. The associated factors for abnormal BP rhythmamong
IgAN patients were the eGFR, serum uric acid, and small vascular hyalinosis.http://dx.doi.org/10.1016/j.hkjn.2015.08.102
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Background: IgG4-RD is known to involve the kidneys. We report two pa-
tients with IgG4-RD and concomitant renal pathology.
Cases: A 61-year-old male presented with microscopic haematuria, renal
impairment [serum creatinine (SCr) 160 umol/mL], proteinuria and anaemia.
Renal biopsy showed features of IgAN. Positron emission tomography scan
revealed generalised lymphadenopathy and splenomegaly. Five years later,
his renal function deteriorated (SCr 326 umol/mL). Cervical lymph node bi-
opsy showed IgG4-related lymphadenopathy. Repeat renal biopsy showed
interstitial nephritis with lymphoplasmacytic infiltration (Figure 1), with
30e40% of IgG-positive plasma cells stained positive for IgG4 (Figure 2),
and features of IgAN. Serum IgG4 level was raised to 1500 mg/dL (range
0e291 mg/dL). He was treated with prednisolone, renal function returned
to baseline in 2 months and serum IgG4 levels also decreased. This patient
remained steroid dependent for the next 5 years. The second patient was
a 62-year-old male who presented with lung mass and nephrotic syndrome.
Computed tomography scan of the thorax showed right lung mass with
lymphadenopathies. Submandibular mass biopsy showed IgG4-related
chronic sclerosing sialadenitis. Renal biopsy showed IgAN with minimal
change-like lesion. There was no tubulointerstitial nephritis and staining
for IgG4 was negative. His serum IgG4 level was elevated. His nephrotic syn-
drome, lymphadenopathy and lung mass all responded to prednisolone ther-
apy. However, nephrotic syndrome relapsed 1 month after stopping steroid
and was steroid dependent.
Conclusion: We reported two patients with IgG4-RD and renal pathology of
IgAN. One patient had IgG4-related kidney disease (IgG4-RKD) confirmed onrenal biopsy. Whilst classical renal histopathology of IgG4-RKD is tubulointer-
stitial nephritis, the two cases showed histological features of IgAN. Both pa-
tients are steroid dependent. IgAN is a common glomerulonephritis in the
oriental population. The presence of both IgAN and IgG4-RD in these patients
could be coincidental. Further studies are needed to assess whether there is
an association between the two conditions.http://dx.doi.org/10.1016/j.hkjn.2015.08.103
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Objective: This study aimed to assess the long-term renal survival rate and
related associated factors of renal progession in IgAN with different sexes.
Methods: This is a single center, retrospective, cohort study. All enrolled
patients were divided into two groups by sex. Clinical and pathological
information were collected and analyzed. The clinical outcomes and
associated factors were evaluated by Kaplan-Meier Estimation and Cox
regression.
Results: A total of 988 eligible IgAN patients (M/F 1:1.4) were enrolled.
Compared to females, males with IgAN exhibited worse renal function,
greater proteinuria, and more frequent occurrence of hypertension,
hypertriglyceridemia and hyperuricemia. Besides, males had more severe
segmental sclerosis and tubular-atrophy/interstitial fibrosis. For females,
hematuria was more frequent. The 3-, 5- and 7-year cumulative renal
survival rates were 92.9%, 84.3%, 73.1% in males; 95.6%, 89.4%, 75.8%
in females, respectively. But no significant difference was noted in the
cumulative renal survival rate between sexes (log-rank test P Z 0.090).
Multivariate Cox regression analyses revealed that sex difference was
not risk factor for renal outcomes after matching baseline eGFR and
SUA. In males, lower eGFR (HR: 0.67, P < 0.001) and degree of glomerular
sclerosis (HR: 1.02, P Z 0.038) were risk factors for renal outcome.
Whereas in females, prognosis factors of renal survival included not
only eGFR (HR: 0.81, P < 0.001) and glomerular sclerosis (HR: 1.03,
P Z 0.001) but also proteinuria (HR: 1.37, P Z 0.002), age (HR: 0.61,
P Z 0.008) and segmental sclerosis (HR: 1.03, P Z 0.035).
Conclusion: This study found that males with IgAN presented worse clinico-
pathological changes than females, but no significant difference was seen in
long-term renal survival between the sexes. Lower eGFR and glomerular
sclerosis were risk factors for renal outcome in both sexes. Higher protein-
uria, younger age and degree of segmental sclerosis were associated with
a worse renal outcome in women but not in men.http://dx.doi.org/10.1016/j.hkjn.2015.08.104
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Objective: To investigate the treatment response and long-term effects of
combination therapy with mycophenolate mofetil (MMF) and glucocorticoids
compared to glucocorticoids alone in IgA nephropathy (IgAN).
Methods: Two hundred and seven IgAN patients with persistent proteinuria (
1 g/day), estimated glomerular filtration (eGFR) > 30 ml/min/1.73 m2 were
enrolled. 126 patients received methyl-prednisolone only (MP group). 81 pa-
tients received MMF and methyl-prednisolone (combination group). The me-
dian follow-up time was 41 months (12e101). The primary endpoint was
defined as double of serum creatinine or progress to end stage renal disease
(ESRD). A decrease in the baseline eGFR of 25% was defined as renal survival.
Results: The urinary proteinuria declined significantly from 2.83 2.48 g/
day to 0.69 0.73 g/day (P < 0.05) in combination group and from
2.88 2.6 g/day to 0.82 1.16 g/day in the MP group (P < 0.05). The
IgA Nephropathy S37complete remission (CR) rates of proteinuria in the combination group and
MP group were 57.35% and 57.28% at the first 12 months of follow-up within
171 patients. Time to CR in the MP group and combination group was 16
(2e44) weeks and 12 (2e36) weeks (P Z 0.237). Time to partial remission
(PR) in the combination group was shorter than in the MP group, 8 (4e36)
weeks versus 12 (4e48) weeks, respectively (PZ 0.037). Kaplan Meier curve
showed the renal survival rate in combination group was significantly higher
than the MP group (ORZ 5.688, PZ 0.017). However, the primary endpoint
was similar in the two groups, 3 patients in the MP group and 2 in the com-
bination group (P Z 0.968).
Conclusion: MMF combined with glucocorticoids could reduce proteinuria as
effectively as glucocorticoids and get shorter time to PR in IgAN patients
with proteinuria  1 g/day. Combined MMF and glucocorticoids treatment
led to a better renal survival compared to glucocorticoids alone in the
long-term follow up.http://dx.doi.org/10.1016/j.hkjn.2015.08.105
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Objective: To understand the clinic-pathological features of the primary IgA
nephropathy (IgAN) with crescentic formation in adults.
Methods: Clinicopathological data of 32 adults with primary Cr IgAN (obser-
vation group) and 56 adults with primary IgAN (control group) were
compared.
Results: Crescent formation has a high incidence (32.6%) in primary IgA
nephropathy. Clinically, most of the patients (86%) showed rapidly pro-
gressive glomerulonephritis. Gross hematuria was noted in 70%, protein-
uria and renal dysfunction significantly increased in observation group
(P < 0.05). Pathologically, cases with fibrinoid necrosis, capillary endo-
thelial proliferation and tubulointerstitial damage were more than the
control group (P < 0.01).
Conclusion: The clinical manifestation and renal lesions of IgAN with cres-
centic in adults are worse than those without, thus we should take positive
clinical treatment to improve the prognosis of this disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.106
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Objective: To analyze the influence of hyperuricemia on renal tubulointer-
stitium in IgA nephropathy patients with normal renal function and provide a
basis for the selection of clinical treatment.
Methods: Retrospective analysis of 86 patients hospitalized in Nephrology
Department in the First Affiliated Hospital of Liaoning Medical University from
July 2011 to July 2014was conducted. The patients’ renal biopsy results showed
primary IgAnephropathyandtheir renal functionwasnormal. Theyweredivided
into normal uric acid group and hyperuricemia group on the basis of uric acid
level, and clinical data reflecting tubulointerstitial injury, renal pathological
data and changes in clinical lab index after treatment of decreasing uric acid
were collected. Statistical method was applied to analyze the results.
Results: Among 86 patients, the normal uric acid group was of 52 cases, 34
cases with hyperuricemia. Clinical observations and pathological features
reflecting tubulointerstitial injury: Compared with normal uric acid group, hy-
peruricemia group had increased urinary b2-microglobulin, urinary retinol
binding protein and urinary N-acetyl-b-D aminoglycosidase and decreased
urine osmotic pressure (P < 0.05), and increased Oxford tubulointerstitial
score and Katafuchi semi quantitative score of renal tubulointerstitium
(P < 0.05). Of the 34 cases, 28 cases received treatment of decreasing uric
acid using allopurinol for 4 weeks and were reviewed regularly. After thetreatment, the patients’ uric acid level significantly decreased, urine osmotic
pressure increased, urinary b2-microglobulin, urinary retinol binding protein
and urinary N-acetyl-b-D-amino-glucosaminidase decreased (P < 0.05).
Table 1. Relationship between blood uric acid level and clinical lab index
ðx  SÞ.
Clinical lab index Normal uric acid Hyperuricemiagroup groupUrine osmotic pressure
(mOsm/kg)817.5  144.5 551.6  63.3Urinary b2-MG (mg/L) 127.5  46.2 414.2  97.6
Urinary RBP (mg/L) 0.18  0.04 0.24  0.05
Urinary NAGL (mg/L) 25.4  6.2 42.6  7.8P ＜ 0.05.
Table 2. Changes in clinical lab index before and after treatment.
Clinical lab index Before treatment After treatmentUrine osmotic pressure (mOsm/kg) 521.6  45.7 668.5  56.8
Urinary b2-MG (mg/L) 423.2  87.5 326.7  84.6
Urinary RBP (mg/L) 0.27  0.06 0.18  0.08
Urinary NAGL (mg/L) 39.7  7.6 28.6  6.9P ＜ 0.05.
Conclusion: IgA nephropathy patients with normal renal function patients
with hyperuricemia had more severe tubular interstitial lesion. They should
be given early intervention on hyperuricemia, which plays an important role
in reducing risk factors and slowing the progression of the disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.107
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Objective: To investigate the relationships between the serum 25-hydroxy
vitamin D3 levels with clinical and pathological features in patients with pri-
mary IgA nephropathy (IgAN), analyse the influence factos of abnormal
levels of 25-hydroxy vitamin D3.
Methods: The clinical and pathological datas of 166 cases wth primary IgA ne-
phropathy were retrospectively analyzed. The study investigated the serum
25-hydroxy vitamin D3 levels and maked a correlation analysis of 25-hydroxy
vitamin D3 levels and IgAN. The prevalence of 25-hydroxy vitamin D3 defi-
ciency or insufficiency was calculated and influence factors with abnormal
25-hydroxy vitamin D3 level were analyzed in the patients with IgAN.
Results: A total of 166 patients with IgAN had complete data and the mean
age was 32.32 13.09 years, of which 82 were males and 84 were females.
The average value of 25-hydroxy vitamin D3 was 43.71 19.93 nmol/L. We
found 93.39% of patients with IgAN in the study had 25-hydroxy vitamin D3
deficiency or insufficiency. The prevalence of normal, deficiency and insuf-
ficiency of 25-hydroxy vitamin D3 were 3.62%, 48.19% and 48.20%, respec-
tively. Blood albumin, eGFR, haemoglobin, IgG, C3 were positively
associated and blood urea nitrogen, uric acid, T-chol, TG, LDL, HDL, ESR,
24-hour urinary protein content, systolic pressure, mesangial cell prolifera-
tion, renal tubule atrophy and interstitial fibrosis were negatively associated
with 25-hydroxy vitamin D3 level (P < 0.05). Serum albumin, eGFR and pro-
teinuria are independent risk factors of abnormal level of 25-hydroxy
vitamin D3 in the patients with IgAN (P < 0.05).
Conclusion:There is significant higher incidenceof 25-hydroxy vitamin D3 defi-
ciency or insufficiency in those patientswith IgAN. The25-hydroxy vitaminD3 is
closely associated with anemia, proteinuria, hyperlipidemia, hypertension
mesangial cell proliferation, renal tubule atrophy and interstitial fibrosis in pa-
tients with IgAN. Serum albumin, eGFR and urine protein are risk factors of
abnormal levels of 25-hydroxy vitamin D3 in those patients with IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.108
